These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26138901)

  • 1. Review: basics of drug development in rheumatology.
    Mina-Osorio P
    Arthritis Rheumatol; 2015 Oct; 67(10):2581-90. PubMed ID: 26138901
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacogenetics in the rheumatic diseases.
    Cronstein BN
    Bull NYU Hosp Jt Dis; 2006; 64(1-2):16-9. PubMed ID: 17121484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intracellular therapeutic procedures].
    Müller-Ladner U; Neumann E
    Z Rheumatol; 2012 Aug; 71(6):459. PubMed ID: 22802022
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacogenomics in pediatric rheumatology.
    Becker ML
    Curr Opin Rheumatol; 2012 Sep; 24(5):541-7. PubMed ID: 22732686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate and long-term treatment of rheumatic disease: comment on the article by Kremer.
    Ranganathan P; McLeod HL
    Arthritis Rheum; 2005 Feb; 52(2):670-1; author reply 672. PubMed ID: 15692997
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel immunological targets in rheumatic diseases: clues from current therapies.
    D'Acquisto F; Rattazzi L; Piras G; Galuppo ML
    Drug Discov Today; 2014 Aug; 19(8):1155-60. PubMed ID: 24984284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antimalarial preparations in rheumatology: new prospects].
    Nasonov EL
    Ter Arkh; 1996; 68(1):67-71. PubMed ID: 8644039
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacogenetics and rheumatology: Molecular mechanisms contributing to variability in drug response.
    Asanuma Y; Xie HG; Stein CM
    Arthritis Rheum; 2005 May; 52(5):1349-59. PubMed ID: 15880820
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tolerance of anti-TNF alpha: the experience acquired in inflammatory rheumatic disease].
    Mariette X
    Ann Dermatol Venereol; 2006 May; 133(5 Pt 2):1S8-12. PubMed ID: 16967603
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology and pharmacokinetics of methotrexate in rheumatic disease. Practical issues in treatment and design.
    Hillson JL; Furst DE
    Rheum Dis Clin North Am; 1997 Nov; 23(4):757-78. PubMed ID: 9361154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Targeted Therapies VI. Proceedings of the 6th International Symposium. Venice, Italy, 28 April-2 May 2004.
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2():ii1-101. PubMed ID: 15479863
    [No Abstract]   [Full Text] [Related]  

  • 12. S100 proteins in rheumatic diseases.
    Austermann J; Spiekermann C; Roth J
    Nat Rev Rheumatol; 2018 Sep; 14(9):528-541. PubMed ID: 30076385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treat-to-target in rheumatology].
    Majdan M
    Wiad Lek; 2015; 68(3):259-64. PubMed ID: 26753210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of methotrexate in rheumatology: results and prospects].
    Nasonov EL
    Klin Med (Mosk); 1996; 74(5):10-5. PubMed ID: 8999172
    [No Abstract]   [Full Text] [Related]  

  • 15. Geropharmacology for the rheumatologist.
    Percy LA; Fang MA
    Rheum Dis Clin North Am; 2000 Aug; 26(3):433-54, v-vi. PubMed ID: 10989506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fetal safety profile of drugs used in the treatment of inflammatory rheumatic diseases].
    Falcão S; Mourão AF; Pimentão JB; Branco JC
    Acta Reumatol Port; 2007; 32(4):323-31. PubMed ID: 18159198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do rheumatology cost-effectiveness analyses make sense?
    Wolfe F; Michaud K; Pincus T
    Rheumatology (Oxford); 2004 Jan; 43(1):4-6. PubMed ID: 14523227
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of biologics in rheumatology: improving the evidence base.
    Silman AJ; Ades AE
    Rheumatology (Oxford); 2011 Sep; 50 Suppl 4():iv1-2. PubMed ID: 21859699
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evidence based medicine in rheumatology].
    Gause A; Raspe HH
    Z Rheumatol; 2002 Oct; 61(5):516-8. PubMed ID: 12399877
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology.
    Gazarian M; Tugwell P; Boers M; Bombardier C; Brooks P; Day R; Strand V; Wells G
    J Rheumatol; 1999 Jan; 26(1):207-9. PubMed ID: 9918265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.